Buerger Exercises With Whole Body Vibration in Diabetic Peripheral Neuropathy
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Dec 16, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment approach for adults aged 50 to 70 who have diabetic peripheral neuropathy, which is a type of nerve damage that can cause pain and balance problems due to diabetes. The researchers want to see if combining specific exercises called Buerger exercises with whole-body vibration therapy can help improve pain, circulation, and balance. Participants will need to do the Buerger exercises three times a day and, if they are in the group receiving the new treatment, they will also attend whole-body vibration sessions three times a week.
To be eligible for this trial, participants must be diagnosed with diabetes for at least five years and have certain levels of blood sugar and nerve damage as measured by specific tests. People with severe pain, major health issues, or serious complications from diabetes won’t be included. Throughout the study, participants will undergo assessments to measure their pain levels, circulation, balance, and mobility at the start, and at four, eight, and twelve weeks, with a follow-up at sixteen weeks. This research could help improve treatment options for those struggling with diabetic nerve pain and balance issues.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Participants with both genders male and female will be included in the study.
- • The Age limit for the participants will be 50-70 years.
- • Patients diagnosed with diabetes from last 5 Years.
- • The participants with Hb1Ac higher than 6.7mmol/L.
- • Patients diagnosed with diabetic peripheral neuropathy with scores ≥ 4 on Michigan Neuropathy Screening Instrument (MNSI).
- • Patients with Ankle Brachial Index \< 1-1.2mmHg.
- • Those patients who were able to participate in exercise interventions.
- Exclusion criteria:
- • The patients with Numeric Pain Rating Scale values greater than 4.
- • Patients with severe cardiovascular or musculoskeletal conditions contraindicating exercise.
- • Patients with serious mental problems or inability to communicate.
- • Patients with Deep venous thrombosis.
- • Patients with Diabetic foot ulcers or foot gangrene.
- • Patients having serious complications of diabetes, such as amputation and patients who are unable to complete the entire program.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Aruba Saeed, PhD
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported